HTGC

NYSE: HTGC (Stock Quote) $13.53 $0.04 0.30%
NYSE: HTGZ (Bond Quote) $25.60 $-0.44 -1.69%
NYSE: HTGY (Bond Quote) $25.51 $-0.33 -1.28%
  • Company
    • Investment Focus
    • Financing Solutions
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Venture Capital & Private Equity
    • Giving Back to the Community
    • Careers
  • Team
    • Investment Professionals
      • Technology
      • Cleantech
      • Life Science
      • Special-Opportunity Lower Middle Market
    • Management
    • Board of Directors
    • Team A-Z
  • Portfolio
    • Technology
    • Cleantech
    • Life Science
    • Special-Opportunity Lower Middle Market
    • Exit History
    • A-Z Portfolio List
  • Investor Relations
    • News & Events
      • Press Releases
      • Webcasts & Events
    • Financials & Filings
      • Analyst Coverage
      • Annual Reports
      • Dividends
        • Dividend Reinvestment Plan
      • Financial Statements
      • Quarterly Results
      • SEC Filings
      • Stock Information
        • Stock Performance
        • Historic Stock Lookup
        • Calculator
      • Tax Information
      • Email Alert Subscription
    • Corporate Governance
      • Corporate Governance Guidelines
      • Audit Committee
      • Compensation Comittee
      • Insider Ownership
      • Insider Transactions
    • Company Information
      • Company Information
      • Executive Management
      • Investor FAQs
      • IR Contact
      • Major Shareholders
    • Credit Ratings
    • What is a BDC
    • Shareholder Tools
      • Investor Briefcase
      • Download Library
      • Printed Materials
      • RSS News Feeds
  • News & Events
    • Press Releases
    • Hercules in the News
    • Portfolio Company News
    • Webcast & Events
  • Venture Debt
  • Contact

Portfolio

Hercules invests in high-growth companies... companies with ambitious goals and the talent to achieve them. As such, we work with companies across multiple stages development from early to expansion stage to post-IPO to help them reach value-building milestones in key technology-related sectors, including cleantech and life.

Case Studies

See how these companies leveraged Hercules financing options to reach key milestones.

  •  
    Ancestry.com
      Finance Stock Purchase
  •  
     
    Aveo Pharmaceuticals, Inc.
      Venture Debt Accelerates New R&D and Supports Rapid Scale-up
  •  
     
    Box.net
      Equipment Purchases and Upgrades Following a Series B Financing
  •  
     
    Cempra, Inc.
      Venture Debt Strengthens Balance Sheet Ahead of IPO
  •  
     
    GreatPoint Energy
      Venture Debt Financing Enables Strategic Alliance
  •  
     
    Hillcrest Labs
      Venture Debt Provides Runway for New Market Expansion
  •  
     
    Nupathe Inc.
      Venture Debt Financing Sets Stage for Product Launch
  •  
     
    Pacira Pharmaceuticals, Inc.
      Venture Debt Helps to Strengthen Balance Sheet Ahead of IPO
  •  
     
    Reply!.com
      Venture Debt Financing for Strategic Acquisitions
  •  
     
    Sonacare Medical
      Venture Debt Accelerates FDA Clinical Submission
Home » Portfolio
  • Technology
  • Cleantech
  • Life Science
  • Special-Opportunity Lower Middle Market
  • A-Z Portfolio List

© 2013 Hercules Technology Growth Capital. All rights reserved. Problems with the site? Email webmaster@htgc.com
Terms of Use & Privacy Policy
*Historical, intraday and current end-of-day data provided by eSignal. Intraday data is at least 20-minutes delayed.